Adam Walsh

Adam Walsh, Analyst Color, Analyst Ratings, Benzinga, Biotech, Coronavirus, COVID-19, fda, Movers, News, Penny Stocks, PHAS, Price Target, Reiteration, Stifel, Trading Ideas

PhaseBio Analyst Says Coronavirus Study Creates Near-Term Catalyst

PhaseBio Pharmaceuticals Inc (NASDAQ: PHAS) shares were skyrocketing Thursday after the company revealed it has received the go-ahead from the FDA for evaluating one of its lead assets for COVID

Latest Ratings for PHAS
DateFirmActionFromTo Apr 20…